A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

NCT06095505 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Alisertib

Sponsor

Puma Biotechnology, Inc.